View in EDS PDF Full Text

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.

Saved in:
Bibliographic Details
Title: The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
Authors: Hirabayashi Y; Department of Rheumatology, Hikarigaoka Spellman Hospital, 6-7-1 Higashisendai, Miyagino-ku, Sendai 983-0833, Japan. mr.hirabayashi@gmail.com, Ishii T
Corporate Authors: Michinoku Tocilizumab Study Group
Source: Clinical rheumatology [Clin Rheumatol] 2013 Jan; Vol. 32 (1), pp. 123-7. Date of Electronic Publication: 2012 Oct 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23090655
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hirabayashi+Y%22">Hirabayashi Y</searchLink>; Department of Rheumatology, Hikarigaoka Spellman Hospital, 6-7-1 Higashisendai, Miyagino-ku, Sendai 983-0833, Japan. mr.hirabayashi@gmail.com<br /><searchLink fieldCode="AU" term="%22Ishii+T%22">Ishii T</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Michinoku+Tocilizumab+Study+Group%22">Michinoku Tocilizumab Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228211469%22">Clinical rheumatology</searchLink> [Clin Rheumatol] 2013 Jan; Vol. 32 (1), pp. 123-7. <i>Date of Electronic Publication: </i>2012 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8211469 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1434-9949 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207703198%22">07703198 </searchLink><i>NLM ISO Abbreviation: </i>Clin Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23090655
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10067-012-2103-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 123
    Titles:
      – TitleFull: The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hirabayashi Y
      – PersonEntity:
          Name:
            NameFull: Ishii T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2013 Jan
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1434-9949
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical rheumatology
              Type: main
ResultId 1